Genes Chromosomes and Cancer · 2011 · 97 citations · 29 references
MedicineMolecular GeneticsPathologyDermatopathologyHistopathologyMolecular DiagnosticsCancer Molecular DiagnosticsFish HistopathologyFish DiagnosticsFish HistologyImmunohistochemical DetectionMolecular Diagnosis From Tissue SamplesMolecular Genetic DiagnosisMultiplex Polymerase Chain Reaction (Pcr)Multiplex Polymerase Chain Reaction AssaysReverse Transcription Polymerase Chain Reaction (Rt-pcr)
Dermatofibrosarcoma protuberans (DFSP) is characterized by the presence of the t(17;22)(q22;q13) that leads to the fusion of the COL1A1 and PDGFB genes. This translocation can be detected by multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) or fluorescence in situ hybridization (FISH) techniques. We have evaluated the usefulness of a dual color dual fusion FISH probe strategy for COL1A1/PDGFB detection in a series of 103 archival DFSPs and compared the obtained results with RT-PCR analyses. FISH and RT-PCR were carried out on paraffin embedded tissue samples. Regarding the RT-PCR approach, all COL1A1 exons and exon 2 of PDGFB were evaluated. Sensitivity, specificity, positive and negative predictive values were assessed considering the histological diagnosis as the gold standard. We also analyzed the relationship between the genetic findings and the clinicopathological variables of the tumors. The COL1A1/PDGFB translocation was detected in 93% of DFSP. Both techniques showed a similar specificity (100%), but FISH was more sensitive than RT-PCR (90% vs. 72%). Regarding, clinicopathological features, a higher percentage of positive cells detected by FISH was significantly associated with the fibrosarcomatous DFSP variant (P < 0.001). Interestingly, all CD34 negative DFSP (n = 5) were positive for COL1A1/PDGFB translocation by both techniques. In conclusion, the majority of DFSP harbor the COL1A1/PDGFB translocation and FISH technique should be recommended as a routine diagnostic tool, especially in cases showing unusual histopathological subtypes and/or immunohistochemical features.
29
Marie‐Pierre Simon, Florence Pédeutour, Nicolas Sirvent et al. · Nature Genetics · 1997 · 528 citations
Life Sciences, Dermatology, Genetics +14
Grant A. McArthur, George D. Demetri, A. van Oosterom et al. · Journal of Clinical Oncology · 2005 · 481 citations
Akira Shimizu, Kerth O’Brien, Tobias Sjöblom et al. · PubMed · 1999 · 289 citations
Dermatofibrosarcoma protuberans: treatment and prognosis.
Emiel J. Rutgers, Kroon Bb, Albus-Lutter Ce et al. · PubMed · 1992 · 288 citations
Medicine, Dermatology, Oncology +10